Business / Finance

RSS

Aradigm first quarter total revenue increases to $0.3 million

Aradigm Corporation today announced financial results for the first quarter and three months ended March 31, 2012.

11 May 2012

PROLOR Biotech prices underwritten public offering of common stock

PROLOR Biotech, Inc., today announced the pricing of its previously announced underwritten public offering of 6.5 million shares of its common stock at a price to the public of $5.00 per share.

11 May 2012

Helix BioMedix first quarter revenue up 90% to $680,000

Helix BioMedix, Inc., a developer of bioactive peptides, today announced financial results for the first quarter ended March 31, 2012.

11 May 2012

iMedX acquires Accumed

iMedX Inc., a leading healthcare software and services company, announced today that it has completed the acquisition of the assets of Accumed Script Inc. With this acquisition, iMedX adds Accumed's many clinics in Ohio to its customer base.

11 May 2012

Eisai, Arena announce expansion of lorcaserin marketing and supply agreement

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today the expansion of the lorcaserin marketing and supply agreement between Arena Pharmaceuticals, Inc.'s wholly owned subsidiary, Arena Pharmaceuticals GmbH, and Eisai Inc. Lorcaserin is an investigational drug candidate intended for weight management.

11 May 2012

BioFuel Energy first quarter net loss increases to $11.1 million

BIOFUEL ENERGY CORP., an ethanol production company, today announced its first quarter 2012 results.

11 May 2012

SXC prices previously announced public offering of common shares

SXC Health Solutions Corp. announced today the pricing of its previously announced public offering of common shares. Under the offering, SXC will sell 5,200,000 of its common shares at a price to the public of $90.60 per share.

11 May 2012

ChromaDex reports total revenues of $1.8 million for first quarter 2012

ChromaDex Corporation an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, cosmetic and pharmaceutical industries, today announced its financial results for the first quarter of 2012.

11 May 2012

Feihe International first quarter revenue decreases to $62.9M

Feihe International, Inc., one of the leading producers and distributors of premium infant formula, milk powder, and soybean, rice and walnut products in China, today announced financial results for the first quarter of 2012.

10 May 2012

Georgia Tech project to design new warehousing and storage system for vaccines, drugs

The Georgia Institute of Technology has received a $100,000 Grand Challenges Explorations grant from the Bill & Melinda Gates Foundation. The program funds individuals worldwide to explore ideas that can break the mold in how persistent global health and development challenges are solved.

10 May 2012

Orexigen reports net loss of $10.4 million for first quarter 2012

Orexigen Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the first quarter of 2012.

10 May 2012

Dehaier Medical first quarter revenues increase 12.3% to $3.3 million

Dehaier Medical Systems Ltd., an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products, today announced its financial results for its first quarter ended March 31, 2012.

10 May 2012

Vocera first quarter revenue increases 26% to $23.1 million

Vocera Communications, Inc., a provider of mobile communication solutions focused on addressing critical communication challenges facing hospitals, today announced results for its first quarter that ended March 31, 2012.

10 May 2012

Cross Country Healthcare first quarter revenue increases 4% to $126.7M

Cross Country Healthcare, Inc. today reported revenue of $126.7 million in the first quarter ended March 31, 2012, a 4% increase from revenue of $122.0 million in the prior year quarter and a 2% increase sequentially from the fourth quarter of 2011.

10 May 2012

Inovio first quarter total revenue decreases to $1.7 million

Inovio Pharmaceuticals, Inc. today reported financial results for the quarter ended March 31, 2012.

10 May 2012

Pacira first quarter total revenues increase to $7.8 million

Pacira Pharmaceuticals, Inc. today announced consolidated financial results for the quarter ended March 31, 2012 and reviewed recent accomplishments, including the commercial launch in the United States of EXPAREL (bupivacaine liposome injectable suspension) for postsurgical pain and the successful completion of an equity financing.

9 May 2012